This inventor holds 3 USPTO granted patents. Top assignees: Schering Corporation, Other. Active years: 1991-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Plantation, FL (US) (1991)
- Hollywood, FL (US) (2002)
Company Filing History:

Years Active: 1991-2002
Title: Innovations by Eugenio A Cefali
Introduction
Eugenio A Cefali is a notable inventor based in Plantation, FL (US). He holds a total of 3 patents that reflect his contributions to medical therapies and formulations. His work primarily focuses on improving treatment methods for hyperlipidemic individuals and developing long-acting pharmaceutical formulations.
Latest Patents
One of his latest patents is titled "Methods of pretreating hyperlipidemic individuals with a flush inhibiting agent prior to the start of single daily dose nicotinic acid therapy to reduce flushing provoked by nicotinic acid." This invention aims to reduce the flushing reactions experienced by individuals undergoing nicotinic acid therapy. The method involves administering flush inhibiting agents, such as nonsteroidal anti-inflammatory agents, orally for a period of 7 to 14 days before starting the therapy. Aspirin is highlighted as a preferred agent, with specific dosage recommendations provided.
Another significant patent is for a "long acting diltiazem formulation." This formulation includes more than 35 percent by weight of a swellable hydrophilic polymer. The release rate of the medication is controlled through a diffusion-controlled membrane applied to the matrix tablet, which is designed to optimize the therapeutic effects of the drug.
Career Highlights
Eugenio A Cefali has worked with reputable organizations, including Schering Corporation. His experience in the pharmaceutical industry has allowed him to develop innovative solutions that address critical health issues.
Collaborations
Throughout his career, he has collaborated with notable professionals such as Surendra A Sangekar and Winston A Vadino. These collaborations have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Eugenio A Cefali's contributions to the field of medicine through his patents demonstrate his commitment to improving patient care and treatment methodologies. His innovative approaches continue to influence the pharmaceutical landscape.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile